⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCAX News
Bicara Therapeutics Inc. Common Stock
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Bicara Therapeutics Announces Closing of Oversubscribed Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
BCAX
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
BCAX
Bicara Therapeutics Announces Proposed Public Offering of Common Stock
globenewswire.com
BCAX
Bicara Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
BCAX
Form 8-K
sec.gov
BCAX
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
globenewswire.com
BCAX
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCAX